Author | Mark E. Robson, MD | OncLive

Author | Mark E. Robson, MD

Articles

Dr. Robson on the Potential Utility of Tucatinib in HER2+ Breast Cancer

March 06, 2020

Video

Mark E. Robson, MD, discusses the potential utility of tucatinib in the treatment of patients with HER2-positive breast cancer.

Dr. Robson on the Application of Precision Medicine in Breast Cancer

January 17, 2020

Video

Mark E. Robson, MD, chief, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, discusses the application of precision medicine in breast cancer.

Dr. Robson on Differences Between Biosimilars and Biologics in Oncology

November 20, 2019

Video

Mark E. Robson, MD, discusses the importance of educational efforts aimed at understanding the differences between biosimilars and biologics in oncology.

Dr. Robson Discusses the Driving Force Behind Biosimilar Use in Oncology

October 29, 2019

Video

Mark E. Robson, MD, chief, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, discusses the driving force behind biosimilar use in oncology.

x